The importance of research in health and longevity is rapidly gaining prominence both nationally and globally. Within this context, Saudi Arabia's Hevolution Foundation plays a leading role, steering international efforts towards tangible, impactful outcomes aligned with the Kingdom’s Vision 2030. Dr. Mehmood Khan, CEO of the Hevolution Foundation, emphasizes that humanity's most significant challenge in longevity and health improvement is not merely discovering scientific breakthroughs but transforming these innovations into sustainable, investable economic sectors.The Hevolution Foundation is firmly committed to advancing this field by investing in cutting-edge scientific research and actively supporting venture capital initiatives that aim to transition discoveries into real-world solutions rapidly. One critical challenge addressed by the foundation is the shortage of qualified human capital specializing in longevity research. To bridge this gap, Hevolution has launched multiple initiatives, including new investigator awards, postdoctoral training programs, academic fellowships, and funded research chairs. These efforts aim to nurture a new generation of researchers and leaders in this vital domain.Another significant challenge the foundation seeks to resolve is the absence of standardized, objective biomarkers for aging and healthspan. This gap substantially hampers research progress. Consequently, Hevolution supports pioneering research focused on identifying reliable, internationally accepted biomarkers, comparable to the revolutionary impact of discovering low-density lipoprotein (LDL) in cardiovascular medicine.Beyond scientific advancements, Dr. Khan and the Hevolution team emphasize the critical need to convert healthspan and longevity into clearly defined investment opportunities. Although the costs of diseases are well-documented, a definitive financial model quantifying the long-term economic value of sustained health remains elusive. To address this, the foundation collaborates with global experts to create new financial frameworks that effectively incentivize private-sector investment in health and longevity.At the policy level, Hevolution actively works to establish a clear regulatory and legal environment, allowing businesses and private entities to market innovations effectively and expand their practical applications. Dr. Khan stresses the importance of governmental support in this investment domain through policies that encourage private sector engagement in longevity and health initiatives.Hevolution's efforts align seamlessly with Saudi Arabia's Vision 2030, which aims not only to raise life expectancy from 76 to 81 years but also to ensure healthier and higher-quality lives for its citizens. The Kingdom recognizes that the true objective is not merely prolonging life, but comprehensively enhancing health to support active, productive lifestyles.According to Dr. Khan, Hevolution's success is measured not only by scientific discoveries or talent development but significantly by its direct influence on policy-making, legislation, and the practical implementation of research. Through advanced research support and extensive collaborations across academia, industry, and government, the foundation is establishing a global standard for innovation in health and longevity.Ultimately, Hevolution views the primary challenge as ensuring the broad application of scientific innovations rather than merely their discovery. Dr. Khan emphasizes that the future of longevity research depends on creating an integrated, transparent regulatory and commercial model capable of delivering the desired global impact.